Related Experiment Video

Updated: Sep 22, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Cholesterol crystal embolization to the digestive system: characterization of a common, yet overlooked presentation

Shomron Ben-Horin1, Eytan Bardan, Iris Barshack

  • 1Department of Medicine F, Sheba Medical Center, Tel Hashomer, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

The American Journal of Gastroenterology
|July 23, 2003
PubMed

Insights

Cholesterol crystal embolism (CCE) frequently affects the digestive system, often presenting with abdominal pain and GI bleeding. Early consideration of CCE is crucial in patients with atherosclerosis and recent vascular procedures.

Area of Science:

  • Cardiovascular Medicine
  • Gastroenterology
  • Pathology

Background:

  • Cholesterol crystal embolism (CCE) is a systemic condition affecting multiple organs.
  • The digestive system is the third most commonly affected system in CCE but is underrepresented in medical literature.
  • This study aims to clinically characterize digestive system involvement in CCE.

Observation:

  • A 7-year review identified 14 CCE cases, with 5 (36%) involving the digestive system.
  • All affected patients had established atherosclerosis; precipitating factors included vascular manipulations or anticoagulation.
  • Manifestations ranged from acute multiorgan failure to chronic gastrointestinal (GI) disease.

Findings:

  • Common GI symptoms included abdominal pain, GI bleeding, fever, and diarrhea.
  • Pathological findings involved bowel infarction, mucosal ulcerations, hepatocellular dysfunction, and pancreatitis.
  • CCE presents with diverse clinical manifestations, impacting the GI tract significantly.

Implications:

  • CCE should be considered in gastroenterological patients with atherosclerosis, especially after vascular procedures or anticoagulation.
  • Recognizing CCE's GI manifestations can lead to earlier diagnosis and management.
  • Further research is needed to fully understand CCE's impact on the digestive system.

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...